Breaking News Instant updates and real-time market news.

STJ

Acquired by ABT

$79.44

1.78 (2.29%)

, ABT

Abbott

$41.17

0.58 (1.43%)

07:18
10/19/16
10/19
07:18
10/19/16
07:18

St. Jude Medical withdraws financial guidance for FY16 due to Abbott transaction

Due to the planned merger with Abbott (ABT), St. Jude Medical (STJ) withdrew financial guidance for the fiscal year 2016.

STJ

Acquired by ABT

$79.44

1.78 (2.29%)

ABT

Abbott

$41.17

0.58 (1.43%)

  • 19

    Oct

  • 19

    Oct

  • 21

    Oct

  • 26

    Oct

  • 06

    Nov

STJ Acquired by ABT
$79.44

1.78 (2.29%)

08/29/16
FBCO
08/29/16
NO CHANGE
FBCO
St. Jude Medical can fix security deficiencies, says Credit Suisse
After speaking with "a developer of software used in drugs/devices" about Muddy Waters' security concerns regarding St. Jude's CRM system, Credit Suisse analyst Matthew Keeler says the consultant believes that the security deficiencies,can be fixed. According to the consultant, the deficiencies can be fixed using a five to ten person team working for about three months, Keeler stated. Keeler does not think that St. Jude's pending acquisition by Abbott (ABT) will be impacted by Muddy Waters' report. He keeps an $81 price target and Neutral rating on St. Jude.
09/08/16
PIPR
09/08/16
NO CHANGE
Target $82
PIPR
Neutral
Piper sees little reason to believe St. Jude deal will not close
Piper Jaffray analyst Brooks West says cybersecurity expert Mark Lanterman during a conference call yesterday refuted security claims by MedSec and Muddy Waters against St. Jude Medical's (STJ) pacemakers, defibrillators and Merlin monitoring system. Lanterman stated that there is "not much meat on the bone" to the MedSec claims and the quality of the analysis, West tells investors in a research note. He notes that Abbott (ABT) yesterday at a competitor conference earlier stated the St. Jude acquisition was progressing toward a close before year-end. The analyst sees little reason to believe the transaction will not close in the planned timeframe. West reiterates a Neutral rating on St. Jude.
09/19/16
JEFF
09/19/16
NO CHANGE
Target $48
JEFF
Buy
Abbott unit sale does not impact Alere transaction, says Jefferies
Jefferies analyst Jeffrey Holford believes Abbott's (ABT) sale of its Medical Optics business to Johnson & Johnson (JNJ) does not imply an increased probability that the Alere (ALR) deal will close. After speaking to Abbott management, Holford thinks the proceeds from the sale are more likely to be targeted towards the St. Jude Medical (STJ) acquisition. He believes that deal has a higher probability of closing than Alere. Holford has a Buy rating on Abbott with a $48 price target.
10/11/16
COWN
10/11/16
NO CHANGE
Target $85
COWN
Outperform
Cowen says St. Jude advisory common for the industry
While Dear Doctor letters are never a positive, St. Jude Medical's (STJ) medical device advisory relating to a low rate of premature battery depletion in the high voltage portfolio is common in the Cardiac Rhythm Management industry, Cowen analyst Joshua Jennings tells investors in a research note. The analyst sees limited risk to St. Jude's franchise and still expects the takeover by Abbott Laboratories' (ABT) to close by the end of the year. Jennings keeps an Outperform rating on St. Jude shares with an $85 price target. The stock is down 1% to $80.19 in pre-market trading.
ABT Abbott
$41.17

0.58 (1.43%)

09/29/16
COWN
09/29/16
NO CHANGE
COWN
Outperform
Cowen says views on Dexcom, Insulet not changed by competitor launches
Cowen analyst Doug Schenkel noted that Abbott (ABT) announced yesterday it had received FDA approval for the professional version of its FreeStyle Libre glucose monitoring product and filed the consumer version of Libre, while Medtronic (MDT) also announced FDA approval of its 670G Hybrid Closed Loop system. Schenkel said Abbott's consumer Libre filing comes a few months ahead of his expectations but that Medtronic's timing was in-line with expectations. The analyst said the competitor announcements, which had been expected, do not change his views on DexCom (DXCM), Insulet (PODD), or Tandem Diabetes (TNDM) and he keeps Outperform ratings on all three of those stocks.
09/29/16
ADAM
09/29/16
NO CHANGE
Target $53
ADAM
Buy
Alere risk-reward looks 'quite good' as deal debate nears end, says Canaccord
Canaccord analyst Mark Massaro said he is optimistic that a conclusion of Abbott (ABT) and Alere's (ALR) merger fight is "not far off" and he still believes Abbott will ultimately acquire Alere, though he also thinks the merger may be decided by a judge. Massaro puts a 65% probability on the likelihood the deal closes at the $56 deal price, a 30% chance that Abbott buys Alere at a lower price nearer to $50 per share, and only a 5% chance the deal breaks, making the risk-reward ratio in Alere shares at current levels "quite good," he tells investors. He trimmed his price target on Alere to $53 from $56 an keeps a Buy rating on the stock.
09/29/16
BARD
09/29/16
NO CHANGE
BARD
Dexcom, Insulet could be weighed down by competitive concerns, says Baird
Baird analyst Jeff Johnson said that while the FDA approvals announced yesterday for Abbott's (ABT) FreeStyle Libre Pro and Medtronic's (MDT) 670G were largely anticipated, he believes that both approvals came sooner than most expected, as did news that Abbott also recently filed for FDA approval of its consumer Libre system. The approvals could "change the narrative" in diabetes and could weigh on others in the sector in the near-term, most notably Dexcom (DXCM) and Insulet (PODD), Johnson tells investors. He keeps Neutral ratings on both and maintains an Overweight rating on Tandem Diabetes (TNDM), citing valuation for the difference.

TODAY'S FREE FLY STORIES

AAPL

Apple

$150.55

-1.34 (-0.88%)

, DGX

Quest Diagnostics

$94.57

-7.54 (-7.38%)

16:23
09/25/17
09/25
16:23
09/25/17
16:23
General news
On The Fly: Top stock stories for Monday »

Stocks began the session…

AAPL

Apple

$150.55

-1.34 (-0.88%)

DGX

Quest Diagnostics

$94.57

-7.54 (-7.38%)

LH

LabCorp

$150.32

-4.75 (-3.06%)

TGT

Target

$58.55

-0.44 (-0.75%)

AIG

AIG

$61.01

0.3 (0.49%)

NAV

Navistar

$42.14

0.81 (1.96%)

VLKAY

Volkswagen

$33.96

-0.61 (-1.76%)

FINL

Finish Line

$10.49

0.76 (7.81%)

NE

Noble Corp.

$4.45

0.32 (7.75%)

CATM

Cardtronics

$26.10

-3.17 (-10.83%)

S

Sprint

$7.82

-0.7 (-8.22%)

SFTBF

SoftBank

$79.96

-2.7 (-3.27%)

TMUS

T-Mobile

$62.89

-1.17 (-1.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 27

    Sep

  • 02

    Oct

  • 22

    Oct

  • 30

    Oct

  • 30

    Nov

  • 16

    May

FN

Fabrinet

$34.78

-1.17 (-3.25%)

, SANM

Sanmina

$36.00

-1.3 (-3.49%)

16:22
09/25/17
09/25
16:22
09/25/17
16:22
Hot Stocks
Fabrinet names Seamus Grady CEO »

Fabrinet (FN) announced…

FN

Fabrinet

$34.78

-1.17 (-3.25%)

SANM

Sanmina

$36.00

-1.3 (-3.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 28

    Sep

  • 29

    Sep

  • 05

    Oct

  • 06

    Oct

  • 18

    Oct

  • 19

    Oct

SNX

Synnex

$116.50

0.4 (0.34%)

16:22
09/25/17
09/25
16:22
09/25/17
16:22
Hot Stocks
Breaking Hot Stocks news story on Synnex »

Synnex up 11% to $130.02…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 16

    Oct

  • 17

    Oct

GFN

General Finance Corp

$4.95

-0.1 (-1.98%)

16:21
09/25/17
09/25
16:21
09/25/17
16:21
Hot Stocks
General Finance Corp announces funding for certain acquisition »

General Finance announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KEX

Kirby

$64.35

0.35 (0.55%)

16:20
09/25/17
09/25
16:20
09/25/17
16:20
Hot Stocks
Breaking Hot Stocks news story on Kirby »

Hushang Ansary reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

SNWV

Sanuwave Health

$0.14

0.015 (12.50%)

16:20
09/25/17
09/25
16:20
09/25/17
16:20
Conference/Events
Sanuwave Health to host business news update conference call »

Management provides a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PKY

Parkway

$23.00

-0.02 (-0.09%)

16:20
09/25/17
09/25
16:20
09/25/17
16:20
Hot Stocks
Parkway announces special cash dividend of $4.00 per share »

Parkway announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

CQP

Cheniere Energy Partners

$27.40

0.37 (1.37%)

16:19
09/25/17
09/25
16:19
09/25/17
16:19
Initiation
Cheniere Energy Partners initiated  »

Cheniere Energy Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RHT

Red Hat

$105.76

-0.54 (-0.51%)

16:19
09/25/17
09/25
16:19
09/25/17
16:19
Hot Stocks
Red Hat reports Q1 subscription revenue up 14% in constant currency »

Subscription revenue from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

PKY

Parkway

$23.00

-0.02 (-0.09%)

16:18
09/25/17
09/25
16:18
09/25/17
16:18
Hot Stocks
Parkway says shareholders approve merger with affiliate of CPPIB »

Parkway announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

LNG

Cheniere Energy

$44.08

0.6 (1.38%)

16:18
09/25/17
09/25
16:18
09/25/17
16:18
Initiation
Cheniere Energy initiated  »

Cheniere Energy initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RHT

Red Hat

$105.76

-0.54 (-0.51%)

16:18
09/25/17
09/25
16:18
09/25/17
16:18
Earnings
Red Hat raises FY18 adjusted EPS view to $2.77-$2.79 from $2.66-$2.70 »

Consensus $2.69. Raises…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

RHT

Red Hat

$105.76

-0.54 (-0.51%)

16:18
09/25/17
09/25
16:18
09/25/17
16:18
Earnings
Red Hat sees Q3 adjusted EPS roughly 70c, consensus 70c »

Sees Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

CRAY

Cray

$18.13

-0.475 (-2.55%)

, STX

Seagate

$33.16

-0.41 (-1.22%)

16:17
09/25/17
09/25
16:17
09/25/17
16:17
Hot Stocks
Cray finishes strategic transaction of Seagate's ClusterStor business »

Cray (CRAY) announced it…

CRAY

Cray

$18.13

-0.475 (-2.55%)

STX

Seagate

$33.16

-0.41 (-1.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNX

Synnex

$116.50

0.4 (0.34%)

16:17
09/25/17
09/25
16:17
09/25/17
16:17
Hot Stocks
SYNNEX raises quarterly dividend 20% to 30c per share »

The dividend will be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 16

    Oct

  • 17

    Oct

$NSD

NASDAQ Market Internals

16:17
09/25/17
09/25
16:17
09/25/17
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNX

Synnex

$116.50

0.4 (0.34%)

16:17
09/25/17
09/25
16:17
09/25/17
16:17
Earnings
SYNNEX sees Q4 adjusted EPS $2.63-$2.73, consensus $2.49 »

Sees Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 16

    Oct

  • 17

    Oct

RHT

Red Hat

$105.73

-0.57 (-0.54%)

16:16
09/25/17
09/25
16:16
09/25/17
16:16
Earnings
Red Hat reports Q2 adjusted EPS 77c, consensus 67c »

Reports Q2 revenue $723M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

SNX

Synnex

$116.59

0.485 (0.42%)

16:16
09/25/17
09/25
16:16
09/25/17
16:16
Hot Stocks
Breaking Hot Stocks news story on Synnex »

SYNNEX raises quarterly…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 16

    Oct

  • 17

    Oct

$NYE

NYSE Market Internals

16:16
09/25/17
09/25
16:16
09/25/17
16:16
Technical Analysis
NYSE market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IVTY

Invuity

$7.80

-0.5 (-6.02%)

16:15
09/25/17
09/25
16:15
09/25/17
16:15
Hot Stocks
Invuity announces commercial launch of PhotonBlade »

Invuit announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 16

    Nov

SNX

Synnex

$116.59

0.485 (0.42%)

16:15
09/25/17
09/25
16:15
09/25/17
16:15
Earnings
Synnex reports Q3 adjusted EPS $2.16, consensus $1.97 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 16

    Oct

  • 17

    Oct

KDMN

Kadmon

$3.83

0.31 (8.81%)

16:13
09/25/17
09/25
16:13
09/25/17
16:13
Syndicate
Kadmon files to sell common stock and warrants »

Kadmon announced its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

PRQR

ProQR Therapeutics

$6.45

0.25 (4.03%)

16:12
09/25/17
09/25
16:12
09/25/17
16:12
Conference/Events
ProQR Therapeutics to hold a conference call »

Management discusses…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 27

    Sep

LAUR

Laureate Education

$14.10

-0.31 (-2.15%)

16:11
09/25/17
09/25
16:11
09/25/17
16:11
Hot Stocks
Breaking Hot Stocks news story on Laureate Education »

12 West Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.